Ipsen (Euronext: IPN) has reported second-quarter sales of 901 million euros ($980 million), up 8% from the same period a ...

UCB, Belgium’s largest drugmaker, today released financial results for first half 2025, showing total revenue in increased to ...

Moderna (Nasdaq: MRNA) has secured European clearance for its latest version of Spikevax (elasomeran) for individuals aged ...

GSK (LSE: GSK) posted a 6% rise in second-quarter sales to £8 billion ($10.7 billion), ahead of analyst forecasts. Pre-tax ...

Swedish biotech Oncopeptides (Nasdaq Stockholm: ONCO) has entered into a partnership with Spanish pharmaceutical broker SD ...

Vinay Prasad has left his post at the US Food and Drug Administration (FDA) less than three months after joining the agency.

USA-based Madrigal Pharmaceuticals today announced that it has entered into an exclusive global license agreement with CSPC ...

Japanese drugmaker Takeda has announced earnings results for the first quarter of Japan’s fiscal year 2025, ending June 30.

The UK’s National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for the use of ...

Swiss pharma company Idorsia today released encouraging first half 2025 financial results, sending its shares up 8.5% to 2.94 ...

Shares of DURECT Corporation shot up 240% to $1.88 by close of trading Tuesday, after Canada’s Bausch Health agreed to ...

Germany’s Evotec today announced a non-binding agreement with Switzerland’s Sandoz regarding the potential sale of Just – ...